Table 4.
Percentage of false susceptibility to third- and fourth-generation cephalosporins in the groups of ESBL and AmpC producers when using the disk diffusion method.
Antibiotic | False susceptibility (%) | |||||
---|---|---|---|---|---|---|
CLSI criteria | EUCAST criteria | |||||
Breakpoint (mm) | ESBL strains (%) | AmpC strains (%) | Breakpoint (mm) | ESBL strains (%) | AmpC strains (%) | |
Cefoperazone | ≥21 | 9 | 43 | not stated | – | – |
Cefotaxime | ≥23 | 8 | 14 | ≥21 | 11 | 29 |
Ceftazidime | ≥18 | 45 | 14 | ≥20 | 38 | 10 |
Cefepime | ≥18 | 52 | – | ≥24 | 19 | – |